Cargando…
Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242943/ https://www.ncbi.nlm.nih.gov/pubmed/32450246 http://dx.doi.org/10.1016/j.meegid.2020.104374 |
_version_ | 1783537332640546816 |
---|---|
author | Raza, Hassan Wahid, Braira Rubi, Ghazala Gulzar, Adil |
author_facet | Raza, Hassan Wahid, Braira Rubi, Ghazala Gulzar, Adil |
author_sort | Raza, Hassan |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infection, complete epidemiological information should be reported on regular basis however, data from Pakistan has not yet been published. This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan. On April 4th, 2020, 128 nasopharyngeal swabs collected from city Faisalabad were transported to Postgraduate Research Institute, Lahore for further processing. RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19. Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128). Prevalence was higher in males (n = 17; 77.2%) as compared to females (n = 5; 22.8%) but this gender-wise difference was not statistically significant. Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19. |
format | Online Article Text |
id | pubmed-7242943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72429432020-05-22 Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience Raza, Hassan Wahid, Braira Rubi, Ghazala Gulzar, Adil Infect Genet Evol Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infection, complete epidemiological information should be reported on regular basis however, data from Pakistan has not yet been published. This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan. On April 4th, 2020, 128 nasopharyngeal swabs collected from city Faisalabad were transported to Postgraduate Research Institute, Lahore for further processing. RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19. Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128). Prevalence was higher in males (n = 17; 77.2%) as compared to females (n = 5; 22.8%) but this gender-wise difference was not statistically significant. Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19. Published by Elsevier B.V. 2020-10 2020-05-22 /pmc/articles/PMC7242943/ /pubmed/32450246 http://dx.doi.org/10.1016/j.meegid.2020.104374 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Raza, Hassan Wahid, Braira Rubi, Ghazala Gulzar, Adil Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title | Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title_full | Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title_fullStr | Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title_full_unstemmed | Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title_short | Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience |
title_sort | molecular epidemiology of sars-cov-2 in faisalabad, pakistan: a real-world clinical experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242943/ https://www.ncbi.nlm.nih.gov/pubmed/32450246 http://dx.doi.org/10.1016/j.meegid.2020.104374 |
work_keys_str_mv | AT razahassan molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience AT wahidbraira molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience AT rubighazala molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience AT gulzaradil molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience |